Elekta Kaiku pioneers the personalization of cancer care through advanced digital patient monitoring and support. The platform enables customization of therapy-specific modules to optimize treatments, maximize their effectiveness, and generate robust real-world data for post-marketing commitments. Elekta Kaiku integrates as a clinical trials digital companion, capturing outcomes that matter to patients.

The company fosters an open partner ecosystem to expand patient reach and provide optimal digital support. It harnesses machine learning technologies combined with clinical and patient-reported data to unlock new possibilities for personalized cancer care. Elekta Kaiku's platform delivers intelligent, real-world digital patient monitoring, improving patient safety, satisfaction, and treatment coordination while also supporting life sciences research through structured real-world data.

Studies show Elekta Kaiku improves patient safety and satisfaction, reduces healthcare system phone call burdens, and enables earlier detection of symptoms. It benefits patients, cancer centers, and research institutions by offering high patient satisfaction, efficient treatment coordination, and structured treatment effectiveness data, respectively.